Trial
NCT05979415
Study to Evaluate the Efficacy and Safety of Staccato Apomorphine (AZ-009) in Patients With Parkinson's Disease Experiencing OFF Episodes
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Alexza Pharmaceuticals, Inc.
Collaborators
Peachtree BioResearch Solutions Inc.; DSG, Inc; ISS, Inc.
Condition
Parkinson Disease
Intervention
Apomorphine Cartridge
Why stopped
Administrative decision
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-10-21